Patents by Inventor Michael Vogelbaum

Michael Vogelbaum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240018602
    Abstract: Provided herein are compositions, systems, kits, and methods for performing an activity based on detecting, in a sample from a cancer patient, the presence of elevated levels of Lactotransferrin (LTF) mRNA or protein, or detecting the presence in the MIF promoter region of at least one of: ?173C and ?794 CATT5-8, and treating a patient with immunotherapy, or generating a report that the subject should be treated with immunotherapy.
    Type: Application
    Filed: November 11, 2021
    Publication date: January 18, 2024
    Inventors: Justin Lathia, Tyler Alban, Defne Baylik, Michael Vogelbaum, Balint Otvos, Matthew Grabowski
  • Publication number: 20230090534
    Abstract: Disclosed herein are compositions and methods for treating glioblastoma in a patient in need thereof by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine) or a pharmaceutically acceptable salt thereof, and an immune checkpoint inhibitor.
    Type: Application
    Filed: September 19, 2022
    Publication date: March 23, 2023
    Applicant: MediciNova, Inc.
    Inventors: Kazuko Matsuda, Michael Vogelbaum, Justin Lathia